Revvity, Inc.

RVTYNYSE • USD
151.53 USD
↗ 2.47 (1.66%)AT CLOSE (03:59 PM EDT)
151.48
↘ 0.06 (0.04%)
POST MARKET (AS OF 08:15 PM EDT)
Post Market
AS OF 08:15 PM EDT
151.48
↘ 0.06 (0.04%)
🔴Market: CLOSED

Shares of Revvity, Inc. (RVTY) are trading at $151.53. The technical outlook is "Strong Buy" and the fundamental picture shows "Neutral". Notable factors include a robust Altman Z-Score, a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation metrics place RVTY at a fair price relative to peers.

Technical & fundamental data as of Oct 2, 2026.

Open?$149.94
High?$153.38
Low?$148.55
Prev. Close?$149.06
Volume?1.2M
Avg. Volume?2.1M
VWAP?$151.41
Rel. Volume?0.59x
Bid / Ask
Bid?$148.15 × 100
Ask?$161.15 × 100
Spread?$13.00
Midpoint?$154.65
Valuation & Ratios
Market Cap?16.9B
Shares Out?111.6M
Float?111.1M
Float %?99.6%
P/E Ratio?71.18
P/B Ratio?2.34
EPS?$2.13
Dividend?0.19%
Ex-Dividend?2026-10-23
News
Profile
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
Employees
11.0K
Market Cap
16.9B
Industry
LABORATORY ANALYTICAL INSTRUMENTS
Listed
1972-06-01
Address
77 4TH AVENUE
WALTHAM, MA 02451
Phone: 781-663-6900
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
77
Z-Score?
78
Momentum?
50
Short Sent.?
49
Piotroski F-Score?6/9Mixed
Altman Z-Score?3.26Safe
Confidence?77%Moderate
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?5.60%Elevated
Short Interest?6.2M
Days to Cover?3.2
Free Float111.1M
Avg Daily Volume2.0M
Settlement Date2026-09-15
Financial Health
Current Ratio?1.80Adequate
Quick Ratio?1.50Adequate
Cash Ratio?0.80Adequate
Debt/Equity?0.44Low
ValuationFAIRLY VALUEDvs 10 peers + S&P 500
Score
56/100
P/E?
Peers
22
S&P
6
71.2PRICEY▾
P/B?
Peers
91
S&P
67
2.34CHEAP▾
P/S?
Peers
55
S&P
23
5.81FAIR▾
P/FCF?
Peers
73
S&P
29
30.3FAIR▾
EV/EBITDA?
Peers
55
S&P
16
24.8HIGH▾
EV/Sales?
Peers
55
S&P
23
6.56HIGH▾
Returns & Efficiency
ROE?
Peers
33
S&P
18
3.3%WEAK▾
ROA?
Peers
22
S&P
19
2.0%WEAK▾
Cash Flow & Enterprise
FCF?$558.1M
Enterprise Value?$19.1B
Fundamentals ratios updated end of day